top of page
News, Events and Updates
Search
Sigma-1 Receptor Implicated in Cell Survival of Rare Neurodegenerative Diseases
Jan 23, 2014
Anavex Agreement with the Roskamp Institute to Advance the Clinical Development of ANAVEX PLUS
Jan 13, 2014
Anavex CEO Invited to Present at Upcoming Investment Conferences
Jan 7, 2014
The Anticipated Clinical Effect of the new AD Drug ANAVEX 2-73 in a Calibrated Quantitative Systems
Dec 11, 2013
Anavex Appoints Clinical Design Expert to Scientific Advisory Board
Dec 10, 2013
Anavex Appoints Alzheimer's Industry Leader to Scientific Advisory Board
Dec 3, 2013
Anavex CEO to Participate in Brean Capital 2013 Life Sciences Summit
Nov 21, 2013
Anavex Announces Expansion of Scientific Advisory Board
Nov 20, 2013
Anavex Reports Predicted Clinical Effect for ANAVEX 2-73 in Computer Simulation Model of AD
Nov 18, 2013
41
42
43
44
45
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
